Randomized Clinical Trial
Copyright ©The Author(s) 2016.
World J Gastroenterol. Oct 21, 2016; 22(39): 8820-8830
Published online Oct 21, 2016. doi: 10.3748/wjg.v22.i39.8820
Table 2 Lesion characteristics
Parametern (%)
Location
Pancreas38 (67.9)
Lymph nodes13 (23.2)
SMT4 (7.1)
Other1 (1.8)
Diameter (mm), mean (SD)33 (12)
Echogenicity on EUS1
Hyper-/hypo-/iso-echoic7 (12.7)/44 (80)/2 (3.6)
Non-homogeneous2 (3.6)
Final diagnosis
Pancreatic adenocarcinoma25 (44.6)
Pancreatic NET7 (12.5)
Lymph node metastasis6 (10.7)
Inflammatory lymph node5 (8.9)
GIST3 (5.4)
Chronic pancreatitis2 (3.6)
Pancreatic metastasis22 (3.6)
Cholangiocarcinoma1 (1.8)
Pancreatic lymphoma1 (1.8)
Lymphoma1 (1.8)
Leiomyoma1 (1.8)
IPMN1 (1.8)
Lymphoma renal infiltration1 (1.8)
Gold standard method
Surgery26 (46.4)
Definite EUS-FNA16 (28.6)
Clinical follow-up (> 12 mo)6 (10.7)
Combination8 (14.3)